Trastuzumab containing regimens for early breast cancer

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Systematic reviews have played a key role in assessing the effects of treatments for women with breast cancer. In a new Cochrane Review in April 2012, Lorenzo Moja from the Department of Public Health at the University of Milan in Italy and colleagues have examined the benefits and harms of the drug Trastuzumab.

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
Download [mp3]  | Read Review
library
Subscribe To all future Podcasts
Subscribe with iTunes
Updated on: May 4, 2012, 12:20

Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org